<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01045993</url>
  </required_header>
  <id_info>
    <org_study_id>TC-09-20</org_study_id>
    <nct_id>NCT01045993</nct_id>
  </id_info>
  <brief_title>A Study To Evaluate Methods To Evaluate Back Pain</brief_title>
  <official_title>A Pilot Study To Evaluate Various Methodologies For Assessing The Treatment Of Low Back Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wyeth is now a wholly owned subsidiary of Pfizer</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wyeth is now a wholly owned subsidiary of Pfizer</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is designed to assess methods used in clinical research.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2010</start_date>
  <completion_date type="Actual">July 2010</completion_date>
  <primary_completion_date type="Actual">July 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to First Perceptible Relief (Confirmed by Meaningful Relief)</measure>
    <time_frame>Baseline (time of wrap application or oral treatment administration) up to 4 hours</time_frame>
    <description>&quot;First perceptible relief&quot; defined as the elapsed time from wrap application or oral treatment until the participant depressed the first stopwatch labeled &quot;first perceptible relief&quot; (any pain relieving effect), provided the participant also depressed the second stopwatch labeled &quot;meaningful relief&quot; (meaningful to participant) by the end of the scheduled in-patient evaluation (4 hours / 240 minutes). If the confirmation was not achieved, the participant was censored at the time when the first stopwatch was depressed. Confidence interval (CI) calculated using the method of Simon &amp; Lee.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to Meaningful Relief</measure>
    <time_frame>Baseline (time of wrap application or oral treatment administration) up to 4 hours</time_frame>
    <description>Time to &quot;meaningful relief&quot; defined as elapsed time from start of treatment until participant depressed the second stopwatch indicating &quot;meaningful relief&quot; (meaningful to participant). Participant consider censored if participant did not depress the stopwatch by end of 4-hour in-patient evaluation, or became a treatment failure (rescue or discontinuation) during the time prior to depressing the second stopwatch. Censoring was at time of dropout if participant withdrew for non-efficacy related reasons during the 4-hour in-patient portion of the study. CI calculated using method of Simon &amp; Lee.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time Weighted Sum of Pain Relief From 0 Through 8 Hours (TOTPAR 0-8)</measure>
    <time_frame>Baseline (time of wrap application or oral treatment administration) up to 8 hours</time_frame>
    <description>TOTPAR 0-8 sum of pain relief from 0 through 8 hours, weighted by the time duration between the current timepoint and the previous timepoint. Pain relief rated hourly (from baseline) by the participant on a 6-point scale: 0=no relief, 1=a little relief, 2=less than half relief, 3=more than half relief, 4=a lot of relief, 5=complete relief. Total possible score 0 to 40; higher score indicated better relief.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time Weighted Sum of Change From Baseline in the Back Stiffness Score Over 8 Hours</measure>
    <time_frame>Baseline (time of wrap application or oral treatment administration) up to 8 hours</time_frame>
    <description>Time weighted sum of change calculated as sum of change from baseline in back stiffness scores from 0 through 8 hours, weighted by time duration between current timepoint and previous timepoint. Based on hourly (from baseline) back stiffness assessment rating from 0 (no muscle stiffness) to 100 (most possible muscle stiffness). Sum of change derived by subtracting score at post-dosing time point from baseline score. Total possible score -800 to 800; higher positive value was indicative of greater improvement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Treatment Failure</measure>
    <time_frame>Baseline (time of wrap application or oral treatment administration) up to 8 hours</time_frame>
    <description>Time to treatment failure defined as time from dosing to the time of rescue medication within the scheduled duration of the study (8 hours); or for participants who withdrew from the study due to lack of efficacy without taking rescue medication, the time of the last assessment was considered the time to treatment failure; or if participant did not take rescue medication, or did not discontinue due to lack of efficacy, the time to treatment failure was considered censored at 8 hours (the scheduled duration of the study).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Individual Time-Point Pain Relief Scores</measure>
    <time_frame>At 60, 120, 180, 240, 300, 360, 420, and 480 minutes</time_frame>
    <description>Pain relief rated hourly (from baseline) by the participant on a 6-point scale: 0=no relief, 1=a little relief, 2=less than half relief, 3=more than half relief, 4=a lot of relief, 5=complete relief.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in Individual Time-point Back Stiffness Scores</measure>
    <time_frame>At 60, 120, 180, 240, 300, 360, 420, and 480 minutes</time_frame>
    <description>Low back muscle stiffness rated hourly (from baseline) by the participant by placing a line on a visual analog scale (VAS) from 0 millimeters (mm) to 100 mm in length with 0=no muscle stiffness up to 100 (most possible stiffness).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline (Bsl) in Combined Flexibility Score: Extension</measure>
    <time_frame>Baseline (time of wrap application or oral treatment administration) and 4 hours</time_frame>
    <description>Flexibility assessed using Paris Plinth table with maximum extension (as if performing a sit-up) of 20 degrees movement. Angle at Bsl and at 4 hours standardized to 100 for assessment of maximum angle (x degrees), x degrees minus 5, and x degrees plus 5. Flexibility score derived using standardized value and VAS score (participant rating of pain by marking level of pain on 100 mm line 0=no pain up to 100=worst pain). Final derived data for extension flexibility were average of the extension flexibility data on the combined score (range -66 to 552); higher value indicated greater improvement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline (Bsl) in Overall Combined Flexibility Score: Side-to-Side</measure>
    <time_frame>Baseline (time of wrap application or oral treatment administration) and 4 hours</time_frame>
    <description>Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus (+/-) 10 degrees for left, and right (L, R), movement. Angle at Bsl and 4 hours standardized to 100 for assessment of maximum angle (x degrees), x degrees - 5, and x degrees + 5. Flexibility score derived using standardized value and VAS score (participant rating of level of pain on 100 mm line 0=no pain to 100=worst pain). Final derived data for overall flexibility was the average of side-to-side (L, R) flexibility data on the combined score (range -81 to 264); higher value=greater improvement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline (Bsl) in Overall Combined Flexibility Score: Rotation</measure>
    <time_frame>Baseline (time of wrap application or oral treatment administration) and 4 hours</time_frame>
    <description>Flexibility assessed using Paris Plinth table with maximum rotation at waist of plus or minus (+/-) 30 degrees for left, and right (L, R), movement. Angle at Bsl and at 4 hours standardized to 100 for assessment of maximum angle (x degrees), x degrees - 5, and x degrees + 5. Flexibility score derived using standardized value and VAS score (participant rating of level of pain on 100 mm line 0=no pain up to 100=worst pain). Final derived data for overall flexibility were the average of rotation (L, R) flexibility data on combined score (range -80 to 155); higher value=greater improvement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in the Angle Measurement at Maximum Flexion for Flexibility Measures: Extension</measure>
    <time_frame>Baseline (time of wrap application or oral treatment administration) and 4 hours</time_frame>
    <description>Participant placed in a prone position on Paris Plinth table which is moved at 1 degree per second to maximum movement of 20 degrees for extension (as if performing a sit-up) to the degree of movement at which participant perceives discomfort or pain. Higher score indicated greater improvement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in the Angle Measurement at Maximum Flexion for Flexibility Measures: Side-to-Side</measure>
    <time_frame>Baseline (time of wrap application or oral treatment administration) and 4 hours</time_frame>
    <description>Participant placed in a prone position on Paris Plinth table which is moved at 1 degree per second to maximum movement +/- 10 degrees for left, and right, side-to-side movement to the degree of movement at which participant perceives discomfort or pain. Maximum flexion based on the average of the left and right side-to-side scores. Higher score indicated greater improvement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in the Angle Measurement at Maximum Flexion for Flexibility Measures: Rotation</measure>
    <time_frame>Baseline (time of wrap application or oral treatment administration) and 4 hours</time_frame>
    <description>Participant placed in a prone position on Paris Plinth table which is moved at 1 degree per second to maximum rotation at waist of +/- 30 degrees for left, and right, movement to the degree of movement at which participant perceives discomfort or pain. Maximum flexion based on the average of the left and right rotation scores. Higher score indicated greater improvement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline (Bsl) in Pain Measurement for Flexibility Measure: Extension</measure>
    <time_frame>Baseline (time of wrap application or oral treatment administration) and 4 hours</time_frame>
    <description>Flexibility assessed using Paris Plinth table with maximum extension of 20 degrees movement (as if performing a sit-up). When participant feels discomfort or pain, participant places a mark to rate discomfort/pain (maximum) on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees (minus) and discomfort rated on VAS. Movement increased 5 degrees (plus) beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher score indicated greater discomfort/pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in Pain Measurement for Flexibility Measure: Side-to-Side</measure>
    <time_frame>Baseline (time of wrap application or oral treatment administration) and 4 hours</time_frame>
    <description>Flexibility assessed using Paris Plinth table with maximum side-to-side movement of +/- 10 degrees for L, R movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain (maximum) on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees (minus) and discomfort rated on VAS. Movement increased 5 degrees (plus) beyond first point when pain was reported and discomfort/pain again rated on the VAS. Analyses based on the average of L, R scores. Higher score indicated greater discomfort/pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in Pain Measurement for Flexibility Measure: Rotation</measure>
    <time_frame>Baseline (time of wrap application or oral treatment administration) and 4 hours</time_frame>
    <description>Flexibility assessed using Paris Plinth table with maximum rotation at waist of +/- 30 degrees for L, R movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain (maximum) on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees (minus) and discomfort rated on VAS. Movement increased 5 degrees (plus) beyond first point when pain was reported and discomfort/pain again rated on the VAS. Analyses based on the average of L, R scores. Higher score indicated greater discomfort/pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Per Categorical Score for Global Assessment of Study Treatment</measure>
    <time_frame>Baseline (time of wrap application or oral treatment administration) up to 8 hours</time_frame>
    <description>At hour 8, or at the time of rescue, if it occurred, participants performed a global assessment in their diary in response to the question: How would you rate the study treatment as a pain reliever? Very Poor=0, Poor=1, Fair=2, Good=3, Very Good=4, Excellent=5.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">61</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Heat device</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Placebo arm</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Marketed analgesic</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>(Oral) Placebo comparator</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Heat Device</intervention_name>
    <description>8-Hour Heatwrap</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Heatwrap</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham Device</intervention_name>
    <description>Inactive wrap worn for 8 hours</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>marketed analgesic</intervention_name>
    <description>2 x 200 mg ibuprofen tablets</description>
    <arm_group_label>3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>2 x placebo tablets</description>
    <arm_group_label>4</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Lower back pain

          -  Male or female in generally good health, from 18 to 55 years of age (inclusive)

        Exclusion Criteria:

          -  Pregnant or lactating

          -  Subject has evidence or history of radiculopathy, i.e. sciatica extending below the
             knee (numbness, tingling, or shooting pain), or other neurologic deficits (abnormal
             straight leg raise test, patellar reflexes, and/or bowel and bladder function);

          -  Subject has a history of previous back surgery;

          -  Subject has back pain resulting from traumatic injury involving physical evidence of
             bruising, swelling, or inflammation to the abdomen or low back area which occurred
             less than 48 hours prior to enrollment

          -  Has taken an investigational drug within the past 30 days prior to entering the study,
             or currently enrolled in another investigational study

          -  Is a member or relative of the study site staff, CRO or Sponsor organization directly
             involved with the study or had a household member or relative participate concurrently
             or previously in this study

          -  Has previously been enrolled in this study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pfizer CT.gov Call Center</last_name>
    <role>Study Director</role>
    <affiliation>Pfizer</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Pfizer Investigational Site</name>
      <address>
        <city>Loma Linda</city>
        <state>California</state>
        <zip>92350</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=TC-09-20&amp;StudyName=A%20Study%20To%20Evaluate%20Methods%20To%20Evaluate%20Back%20Pain</url>
    <description>To obtain contact information for a study center near you, click here.</description>
  </link>
  <verification_date>February 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 8, 2010</study_first_submitted>
  <study_first_submitted_qc>January 8, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 11, 2010</study_first_posted>
  <results_first_submitted>December 5, 2011</results_first_submitted>
  <results_first_submitted_qc>February 21, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">April 1, 2013</results_first_posted>
  <last_update_submitted>February 21, 2013</last_update_submitted>
  <last_update_submitted_qc>February 21, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 1, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pilot Study to Assess Methodologies</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Back Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Analgesics</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants were recruited who had primary muscular low back pain (in the Investigator’s best judgment), which was atraumatic (no traumatic injury within 48 hours of enrollment) and not caused by, or related to, any clinically significant, medical diseases, whose onset had occurred within the past 3 months.</recruitment_details>
      <pre_assignment_details>Eligible participants with at least moderate pain intensity on a 6-point categorical scale were randomized (N=61) to primary efficacy (heatwrap or oral placebo) or blinding groups (“sham” wrap or oral Ibuprofen). May have received rescue medication (oral acetaminophen) during the 4-hour evaluation period or at discharge after assessments completed.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>ThermaCare®</title>
          <description>Active treatment low back/hip heatwrap administered one time (could be applied for up to 8 hours); applied within 5 minutes of unsealing the foil wrapper.</description>
        </group>
        <group group_id="P2">
          <title>Sham Wrap (Inactive)</title>
          <description>Inactive heatwrap administered one time as a non-heating wrap; applied within 5 minutes of unsealing the foil wrapper.</description>
        </group>
        <group group_id="P3">
          <title>Oral Ibuprofen (IBU)</title>
          <description>IBU (commercially available Advil®) administered as two 200 milligram (mg) tablets by mouth (PO) as a one time dose.</description>
        </group>
        <group group_id="P4">
          <title>Oral Placebo</title>
          <description>Oral Placebo matching Oral IBU.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="5"/>
                <participants group_id="P4" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="5"/>
                <participants group_id="P4" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Treated-later found eligibility not met</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>ThermaCare®</title>
          <description>Active treatment low back/hip heatwrap administered one time (could be applied for up to 8 hours); applied within 5 minutes of unsealing the foil wrapper.</description>
        </group>
        <group group_id="B2">
          <title>Sham Wrap (Inactive)</title>
          <description>Inactive heatwrap administered one time as a non-heating wrap; applied within 5 minutes of unsealing the foil wrapper.</description>
        </group>
        <group group_id="B3">
          <title>Oral Ibuprofen (IBU)</title>
          <description>IBU (commercially available Advil®) administered as two 200 milligram (mg) tablets by mouth (PO) as a one time dose.</description>
        </group>
        <group group_id="B4">
          <title>Oral Placebo</title>
          <description>Oral Placebo matching Oral IBU.</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="26"/>
            <count group_id="B2" value="5"/>
            <count group_id="B3" value="5"/>
            <count group_id="B4" value="25"/>
            <count group_id="B5" value="61"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30.0" spread="6.0"/>
                    <measurement group_id="B2" value="25.6" spread="5.4"/>
                    <measurement group_id="B3" value="30.0" spread="7.2"/>
                    <measurement group_id="B4" value="28.8" spread="7.7"/>
                    <measurement group_id="B5" value="29.1" spread="6.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="15"/>
                    <measurement group_id="B5" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="10"/>
                    <measurement group_id="B5" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Number of participants with categorical score for pain intensity</title>
          <description>Participant rated the severity of their pain on a 6-point scale in response to the question &quot;How much pain are you experiencing in your lower back right now&quot;. Scored as None=0, Mild=1, Moderate=2, Moderately severe=3, Severe=4, Extreme=5. Participant was asked to remember the level of pain experienced at this time as a reference for any pain relief experienced at later time points.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>None=0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mild=1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Moderate=2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="20"/>
                    <measurement group_id="B5" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Moderately severe=3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="4"/>
                    <measurement group_id="B5" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Severe=4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Extreme=5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Back Stiffness Score</title>
          <description>Participant rated their low back muscle stiffness by placing a line on a visual analog scale (VAS) in response to the question “Please indicate a number from 0 through 100 that best describes your low back muscle stiffness”. VAS scaled as 0 millimeters (mm) to 100 mm in length with 0 (no muscle stiffness) up to 100 (most possible stiffness).</description>
          <units>millimeters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="45.85" spread="13.18"/>
                    <measurement group_id="B2" value="55.00" spread="18.71"/>
                    <measurement group_id="B3" value="50.00" spread="10.61"/>
                    <measurement group_id="B4" value="51.24" spread="20.32"/>
                    <measurement group_id="B5" value="49.15" spread="16.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Flexibility Assessment: Extension (Angle)</title>
          <description>Flexibility assessed using Paris Plinth table with maximum extension (as if performing a sit-up) of 20 degrees movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.</description>
          <units>degree of angle</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <title>Maximum degrees</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15.31" spread="4.53"/>
                    <measurement group_id="B2" value="16.48" spread="4.82"/>
                    <measurement group_id="B3" value="16.80" spread="3.89"/>
                    <measurement group_id="B4" value="14.07" spread="4.51"/>
                    <measurement group_id="B5" value="15.02" spread="4.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Minus 5 degrees</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10.19" spread="4.38"/>
                    <measurement group_id="B2" value="11.26" spread="5.04"/>
                    <measurement group_id="B3" value="11.62" spread="3.70"/>
                    <measurement group_id="B4" value="9.01" spread="4.28"/>
                    <measurement group_id="B5" value="9.91" spread="4.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Plus 5 degrees (beyond maximum)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17.28" spread="4.48"/>
                    <measurement group_id="B2" value="18.50" spread="2.24"/>
                    <measurement group_id="B3" value="18.78" spread="4.35"/>
                    <measurement group_id="B4" value="17.59" spread="4.02"/>
                    <measurement group_id="B5" value="17.63" spread="4.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Flexibility Assessment: Extension (visual analog scale ([VAS])</title>
          <description>Flexibility assessed using Paris Plinth table with maximum extension (as if performing a sit-up) of 20 degrees movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.</description>
          <units>millimeters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <title>VAS at Maximum degrees</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="48.65" spread="15.69"/>
                    <measurement group_id="B2" value="41.00" spread="21.21"/>
                    <measurement group_id="B3" value="48.20" spread="13.52"/>
                    <measurement group_id="B4" value="43.40" spread="23.35"/>
                    <measurement group_id="B5" value="45.84" spread="19.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>VAS at Minus 5 degrees</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33.54" spread="19.41"/>
                    <measurement group_id="B2" value="26.60" spread="22.00"/>
                    <measurement group_id="B3" value="34.00" spread="11.51"/>
                    <measurement group_id="B4" value="29.36" spread="22.37"/>
                    <measurement group_id="B5" value="31.30" spread="20.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>VAS at Plus 5 degrees (beyond maximum)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="56.92" spread="20.27"/>
                    <measurement group_id="B2" value="50.00" spread="32.64"/>
                    <measurement group_id="B3" value="59.40" spread="14.28"/>
                    <measurement group_id="B4" value="52.60" spread="27.47"/>
                    <measurement group_id="B5" value="54.79" spread="23.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Flexibility Assessment: Side-to-Side (Angle)</title>
          <description>Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left (L), and right (R), movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.</description>
          <units>degree of angle</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <title>L Maximum degrees</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6.92" spread="1.69"/>
                    <measurement group_id="B2" value="7.20" spread="1.79"/>
                    <measurement group_id="B3" value="6.50" spread="2.40"/>
                    <measurement group_id="B4" value="7.16" spread="1.50"/>
                    <measurement group_id="B5" value="7.01" spread="1.65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>R Maximum degrees</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6.80" spread="1.76"/>
                    <measurement group_id="B2" value="7.40" spread="1.34"/>
                    <measurement group_id="B3" value="6.50" spread="2.06"/>
                    <measurement group_id="B4" value="6.76" spread="1.80"/>
                    <measurement group_id="B5" value="6.81" spread="1.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>L Minus 5 degrees</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2.15" spread="1.19"/>
                    <measurement group_id="B2" value="2.40" spread="1.34"/>
                    <measurement group_id="B3" value="2.00" spread="1.41"/>
                    <measurement group_id="B4" value="2.32" spread="1.07"/>
                    <measurement group_id="B5" value="2.23" spread="1.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>R Minus 5 degrees</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2.05" spread="1.27"/>
                    <measurement group_id="B2" value="2.40" spread="1.34"/>
                    <measurement group_id="B3" value="1.80" spread="1.64"/>
                    <measurement group_id="B4" value="1.92" spread="1.19"/>
                    <measurement group_id="B5" value="2.00" spread="1.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>L Plus 5 degrees (beyond maximum)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7.22" spread="1.66"/>
                    <measurement group_id="B2" value="7.40" spread="1.34"/>
                    <measurement group_id="B3" value="6.60" spread="2.19"/>
                    <measurement group_id="B4" value="7.42" spread="1.40"/>
                    <measurement group_id="B5" value="7.26" spread="1.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>R Plus 5 degrees (beyond maximum)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7.33" spread="1.41"/>
                    <measurement group_id="B2" value="7.70" spread="0.67"/>
                    <measurement group_id="B3" value="7.00" spread="1.39"/>
                    <measurement group_id="B4" value="7.02" spread="1.68"/>
                    <measurement group_id="B5" value="7.20" spread="1.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Flexibility Assessment: Side-to-side (VAS)</title>
          <description>Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus 10 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.</description>
          <units>millimeters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <title>L VAS at Maximum degrees</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="42.69" spread="22.61"/>
                    <measurement group_id="B2" value="32.40" spread="14.64"/>
                    <measurement group_id="B3" value="43.60" spread="21.28"/>
                    <measurement group_id="B4" value="35.24" spread="25.87"/>
                    <measurement group_id="B5" value="38.87" spread="23.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>R VAS at Maximum degrees</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="47.38" spread="25.18"/>
                    <measurement group_id="B2" value="40.40" spread="20.97"/>
                    <measurement group_id="B3" value="52.20" spread="14.45"/>
                    <measurement group_id="B4" value="45.40" spread="20.69"/>
                    <measurement group_id="B5" value="46.39" spread="22.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>L VAS at Minus 5 degrees</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24.85" spread="22.82"/>
                    <measurement group_id="B2" value="15.20" spread="9.47"/>
                    <measurement group_id="B3" value="28.20" spread="14.46"/>
                    <measurement group_id="B4" value="22.80" spread="18.77"/>
                    <measurement group_id="B5" value="23.49" spread="19.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>R VAS at Minus 5 degrees</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24.35" spread="19.57"/>
                    <measurement group_id="B2" value="19.80" spread="13.92"/>
                    <measurement group_id="B3" value="34.00" spread="19.96"/>
                    <measurement group_id="B4" value="24.96" spread="18.75"/>
                    <measurement group_id="B5" value="25.02" spread="18.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>L VAS at Plus 5 degrees (beyond maximum)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40.58" spread="26.10"/>
                    <measurement group_id="B2" value="27.80" spread="15.42"/>
                    <measurement group_id="B3" value="48.20" spread="22.83"/>
                    <measurement group_id="B4" value="37.64" spread="25.93"/>
                    <measurement group_id="B5" value="38.95" spread="24.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>R VAS at Plus 5 degrees (beyond maximum)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="48.42" spread="26.16"/>
                    <measurement group_id="B2" value="42.40" spread="22.03"/>
                    <measurement group_id="B3" value="55.60" spread="13.63"/>
                    <measurement group_id="B4" value="44.92" spread="21.85"/>
                    <measurement group_id="B5" value="47.08" spread="23.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Flexibility Assessment: Rotation (Angle)</title>
          <description>Flexibility assessed using Paris Plinth table with maximum rotation at waist movement of plus or minus 30 degrees for left, and right, movement. Angle at baseline standardized to 100 for assessment of maximum angle (x degrees) up to the degree of movement at which participant perceives discomfort or pain, x degrees minus 5, and x degrees plus 5. Greater degree of angle indicated greater flexibility.</description>
          <units>degree of angle</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <title>L Maximum degrees</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15.67" spread="4.08"/>
                    <measurement group_id="B2" value="17.36" spread="3.77"/>
                    <measurement group_id="B3" value="15.96" spread="6.44"/>
                    <measurement group_id="B4" value="17.03" spread="4.40"/>
                    <measurement group_id="B5" value="16.39" spread="4.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>R Maximum degrees</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16.78" spread="4.73"/>
                    <measurement group_id="B2" value="16.66" spread="4.26"/>
                    <measurement group_id="B3" value="16.62" spread="6.19"/>
                    <measurement group_id="B4" value="16.91" spread="4.78"/>
                    <measurement group_id="B5" value="16.81" spread="4.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>L Minus 5 degrees</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10.21" spread="4.12"/>
                    <measurement group_id="B2" value="11.30" spread="4.09"/>
                    <measurement group_id="B3" value="10.42" spread="6.19"/>
                    <measurement group_id="B4" value="11.46" spread="4.33"/>
                    <measurement group_id="B5" value="10.83" spread="4.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>R Minus 5 degrees</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11.27" spread="4.48"/>
                    <measurement group_id="B2" value="11.28" spread="4.38"/>
                    <measurement group_id="B3" value="10.74" spread="6.12"/>
                    <measurement group_id="B4" value="11.56" spread="4.46"/>
                    <measurement group_id="B5" value="11.34" spread="4.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>L Plus 5 degrees (beyond maximum)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17.95" spread="3.28"/>
                    <measurement group_id="B2" value="17.66" spread="3.73"/>
                    <measurement group_id="B3" value="17.12" spread="5.13"/>
                    <measurement group_id="B4" value="18.24" spread="4.12"/>
                    <measurement group_id="B5" value="17.98" spread="3.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>R Plus 5 degrees (beyond maximum)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18.48" spread="4.14"/>
                    <measurement group_id="B2" value="18.46" spread="3.73"/>
                    <measurement group_id="B3" value="18.06" spread="4.39"/>
                    <measurement group_id="B4" value="18.32" spread="4.30"/>
                    <measurement group_id="B5" value="18.38" spread="4.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Flexibility Assessment: Rotation (VAS)</title>
          <description>Flexibility assessed using Paris Plinth table with maximum rotation at waist of plus or minus 30 degrees for left, and right, movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees and discomfort rated on VAS. Movement increased 5 degrees beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher scores indicated greater pain.</description>
          <units>millimeters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <title>L VAS at Maximum degrees</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="52.54" spread="23.88"/>
                    <measurement group_id="B2" value="60.00" spread="23.74"/>
                    <measurement group_id="B3" value="60.60" spread="12.30"/>
                    <measurement group_id="B4" value="48.80" spread="23.41"/>
                    <measurement group_id="B5" value="52.28" spread="22.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>R VAS at Maximum degrees</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="51.65" spread="21.33"/>
                    <measurement group_id="B2" value="59.40" spread="31.09"/>
                    <measurement group_id="B3" value="61.60" spread="15.84"/>
                    <measurement group_id="B4" value="49.64" spread="25.97"/>
                    <measurement group_id="B5" value="52.28" spread="23.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>L VAS at Minus 5 degrees</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="36.92" spread="21.25"/>
                    <measurement group_id="B2" value="47.20" spread="22.94"/>
                    <measurement group_id="B3" value="46.60" spread="21.24"/>
                    <measurement group_id="B4" value="33.24" spread="22.28"/>
                    <measurement group_id="B5" value="37.05" spread="21.77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>R VAS at Minus 5 degrees</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="38.15" spread="22.26"/>
                    <measurement group_id="B2" value="44.20" spread="27.47"/>
                    <measurement group_id="B3" value="47.40" spread="15.84"/>
                    <measurement group_id="B4" value="36.56" spread="25.02"/>
                    <measurement group_id="B5" value="38.75" spread="23.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>L VAS at Plus 5 degrees (beyond maximum)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="56.62" spread="25.62"/>
                    <measurement group_id="B2" value="63.80" spread="18.79"/>
                    <measurement group_id="B3" value="65.80" spread="12.19"/>
                    <measurement group_id="B4" value="49.24" spread="22.12"/>
                    <measurement group_id="B5" value="54.93" spread="23.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>R VAS at Plus 5 degrees (beyond maximum)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="59.12" spread="27.10"/>
                    <measurement group_id="B2" value="66.40" spread="28.17"/>
                    <measurement group_id="B3" value="64.20" spread="11.50"/>
                    <measurement group_id="B4" value="50.92" spread="26.61"/>
                    <measurement group_id="B5" value="56.77" spread="26.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Secondary</type>
        <title>Time to Meaningful Relief</title>
        <description>Time to “meaningful relief” defined as elapsed time from start of treatment until participant depressed the second stopwatch indicating “meaningful relief” (meaningful to participant). Participant consider censored if participant did not depress the stopwatch by end of 4-hour in-patient evaluation, or became a treatment failure (rescue or discontinuation) during the time prior to depressing the second stopwatch. Censoring was at time of dropout if participant withdrew for non-efficacy related reasons during the 4-hour in-patient portion of the study. CI calculated using method of Simon &amp; Lee.</description>
        <time_frame>Baseline (time of wrap application or oral treatment administration) up to 4 hours</time_frame>
        <population>ITT population. Median and/or upper limit of CI reported as 240 minutes if median or upper limit &gt;240 minutes.</population>
        <group_list>
          <group group_id="O1">
            <title>ThermaCare®</title>
            <description>Active treatment low back/hip heatwrap administered one time (could be applied for up to 8 hours); applied within 5 minutes of unsealing the foil wrapper.</description>
          </group>
          <group group_id="O2">
            <title>Sham Wrap (Inactive)</title>
            <description>Inactive heatwrap administered one time as a non-heating wrap; applied within 5 minutes of unsealing the foil wrapper.</description>
          </group>
          <group group_id="O3">
            <title>Oral Ibuprofen (IBU)</title>
            <description>IBU (commercially available Advil®) administered as two 200 milligram (mg) tablets by mouth (PO) as a one time dose.</description>
          </group>
          <group group_id="O4">
            <title>Oral Placebo</title>
            <description>Oral Placebo matching Oral IBU.</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Meaningful Relief</title>
          <description>Time to “meaningful relief” defined as elapsed time from start of treatment until participant depressed the second stopwatch indicating “meaningful relief” (meaningful to participant). Participant consider censored if participant did not depress the stopwatch by end of 4-hour in-patient evaluation, or became a treatment failure (rescue or discontinuation) during the time prior to depressing the second stopwatch. Censoring was at time of dropout if participant withdrew for non-efficacy related reasons during the 4-hour in-patient portion of the study. CI calculated using method of Simon &amp; Lee.</description>
          <population>ITT population. Median and/or upper limit of CI reported as 240 minutes if median or upper limit &gt;240 minutes.</population>
          <units>minutes</units>
          <param>Median</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="5"/>
                <count group_id="O3" value="5"/>
                <count group_id="O4" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="215.7" lower_limit="163.7" upper_limit="240"/>
                    <measurement group_id="O2" value="104.0" lower_limit="71.0" upper_limit="240"/>
                    <measurement group_id="O3" value="135.1" lower_limit="119.8" upper_limit="240"/>
                    <measurement group_id="O4" value="240">CI was not calculated as time to meaningful pain relief was &gt;240 minutes.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.046</p_value>
            <p_value_desc>Statistically significant treatment difference was declared if the probability of random occurrence between the treatment groups p-value was ≤0.05.</p_value_desc>
            <method>Proportional hazards regression model</method>
            <method_desc>P-value calculated using proportional hazards model with treatment term only in the model.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Time to First Perceptible Relief (Confirmed by Meaningful Relief)</title>
        <description>“First perceptible relief” defined as the elapsed time from wrap application or oral treatment until the participant depressed the first stopwatch labeled “first perceptible relief” (any pain relieving effect), provided the participant also depressed the second stopwatch labeled &quot;meaningful relief” (meaningful to participant) by the end of the scheduled in-patient evaluation (4 hours / 240 minutes). If the confirmation was not achieved, the participant was censored at the time when the first stopwatch was depressed. Confidence interval (CI) calculated using the method of Simon &amp; Lee.</description>
        <time_frame>Baseline (time of wrap application or oral treatment administration) up to 4 hours</time_frame>
        <population>Intent-to-treat population (ITT): all randomized participants who applied/dosed with study product and had a baseline assessment. Median and/or upper limit of CI reported as 240 minutes if &gt;240 minutes. No primary endpoint was prespecified in this Pilot study; 1 key efficacy endpoint was selected for reporting purposes only.</population>
        <group_list>
          <group group_id="O1">
            <title>ThermaCare®</title>
            <description>Active treatment low back/hip heatwrap administered one time (could be applied for up to 8 hours); applied within 5 minutes of unsealing the foil wrapper.</description>
          </group>
          <group group_id="O2">
            <title>Sham Wrap (Inactive)</title>
            <description>Inactive heatwrap administered one time as a non-heating wrap; applied within 5 minutes of unsealing the foil wrapper.</description>
          </group>
          <group group_id="O3">
            <title>Oral Ibuprofen (IBU)</title>
            <description>IBU (commercially available Advil®) administered as two 200 milligram (mg) tablets by mouth (PO) as a one time dose.</description>
          </group>
          <group group_id="O4">
            <title>Oral Placebo</title>
            <description>Oral Placebo matching Oral IBU.</description>
          </group>
        </group_list>
        <measure>
          <title>Time to First Perceptible Relief (Confirmed by Meaningful Relief)</title>
          <description>“First perceptible relief” defined as the elapsed time from wrap application or oral treatment until the participant depressed the first stopwatch labeled “first perceptible relief” (any pain relieving effect), provided the participant also depressed the second stopwatch labeled &quot;meaningful relief” (meaningful to participant) by the end of the scheduled in-patient evaluation (4 hours / 240 minutes). If the confirmation was not achieved, the participant was censored at the time when the first stopwatch was depressed. Confidence interval (CI) calculated using the method of Simon &amp; Lee.</description>
          <population>Intent-to-treat population (ITT): all randomized participants who applied/dosed with study product and had a baseline assessment. Median and/or upper limit of CI reported as 240 minutes if &gt;240 minutes. No primary endpoint was prespecified in this Pilot study; 1 key efficacy endpoint was selected for reporting purposes only.</population>
          <units>minutes</units>
          <param>Median</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="5"/>
                <count group_id="O3" value="5"/>
                <count group_id="O4" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="96.5" lower_limit="26.4" upper_limit="240"/>
                    <measurement group_id="O2" value="38.7" lower_limit="7.5" upper_limit="240"/>
                    <measurement group_id="O3" value="54.0" lower_limit="31.3" upper_limit="240"/>
                    <measurement group_id="O4" value="240">CI was not calculated as time to first perceptible pain relief was &gt;240 minutes.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The statistical alternative hypothesis tested is that the survival curves of time to first perceptible relief confirmed by meaningful relief are not identical between two treatment groups, or equivalently, the hazard ratio between two treatment groups is not equal to 1.</non_inferiority_desc>
            <p_value>0.046</p_value>
            <p_value_desc>Statistically significant treatment difference was declared if the probability of random occurrence between the treatment groups p-value was ≤0.05.</p_value_desc>
            <method>Proportional hazards regression model</method>
            <method_desc>P-value calculated using proportional hazards model with treatment term only in the model.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time Weighted Sum of Pain Relief From 0 Through 8 Hours (TOTPAR 0-8)</title>
        <description>TOTPAR 0-8 sum of pain relief from 0 through 8 hours, weighted by the time duration between the current timepoint and the previous timepoint. Pain relief rated hourly (from baseline) by the participant on a 6-point scale: 0=no relief, 1=a little relief, 2=less than half relief, 3=more than half relief, 4=a lot of relief, 5=complete relief. Total possible score 0 to 40; higher score indicated better relief.</description>
        <time_frame>Baseline (time of wrap application or oral treatment administration) up to 8 hours</time_frame>
        <population>ITT population.</population>
        <group_list>
          <group group_id="O1">
            <title>ThermaCare®</title>
            <description>Active treatment low back/hip heatwrap administered one time (could be applied for up to 8 hours); applied within 5 minutes of unsealing the foil wrapper.</description>
          </group>
          <group group_id="O2">
            <title>Sham Wrap (Inactive)</title>
            <description>Inactive heatwrap administered one time as a non-heating wrap; applied within 5 minutes of unsealing the foil wrapper.</description>
          </group>
          <group group_id="O3">
            <title>Oral Ibuprofen (IBU)</title>
            <description>IBU (commercially available Advil®) administered as two 200 milligram (mg) tablets by mouth (PO) as a one time dose.</description>
          </group>
          <group group_id="O4">
            <title>Oral Placebo</title>
            <description>Oral Placebo matching Oral IBU.</description>
          </group>
        </group_list>
        <measure>
          <title>Time Weighted Sum of Pain Relief From 0 Through 8 Hours (TOTPAR 0-8)</title>
          <description>TOTPAR 0-8 sum of pain relief from 0 through 8 hours, weighted by the time duration between the current timepoint and the previous timepoint. Pain relief rated hourly (from baseline) by the participant on a 6-point scale: 0=no relief, 1=a little relief, 2=less than half relief, 3=more than half relief, 4=a lot of relief, 5=complete relief. Total possible score 0 to 40; higher score indicated better relief.</description>
          <population>ITT population.</population>
          <units>scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="5"/>
                <count group_id="O3" value="5"/>
                <count group_id="O4" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.0" spread="7.9"/>
                    <measurement group_id="O2" value="15.6" spread="13.1"/>
                    <measurement group_id="O3" value="17.0" spread="13.5"/>
                    <measurement group_id="O4" value="11.5" spread="10.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Statistically significant treatment difference was declared if the probability of random occurrence between the treatment groups p-value was ≤0.05.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>P-value calculated using analysis of variance (ANOVA) model with treatment term only in the model.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time Weighted Sum of Change From Baseline in the Back Stiffness Score Over 8 Hours</title>
        <description>Time weighted sum of change calculated as sum of change from baseline in back stiffness scores from 0 through 8 hours, weighted by time duration between current timepoint and previous timepoint. Based on hourly (from baseline) back stiffness assessment rating from 0 (no muscle stiffness) to 100 (most possible muscle stiffness). Sum of change derived by subtracting score at post-dosing time point from baseline score. Total possible score -800 to 800; higher positive value was indicative of greater improvement.</description>
        <time_frame>Baseline (time of wrap application or oral treatment administration) up to 8 hours</time_frame>
        <population>ITT population.</population>
        <group_list>
          <group group_id="O1">
            <title>ThermaCare®</title>
            <description>Active treatment low back/hip heatwrap administered one time (could be applied for up to 8 hours); applied within 5 minutes of unsealing the foil wrapper.</description>
          </group>
          <group group_id="O2">
            <title>Sham Wrap (Inactive)</title>
            <description>Inactive heatwrap administered one time as a non-heating wrap; applied within 5 minutes of unsealing the foil wrapper.</description>
          </group>
          <group group_id="O3">
            <title>Oral Ibuprofen (IBU)</title>
            <description>IBU (commercially available Advil®) administered as two 200 milligram (mg) tablets by mouth (PO) as a one time dose.</description>
          </group>
          <group group_id="O4">
            <title>Oral Placebo</title>
            <description>Oral Placebo matching Oral IBU.</description>
          </group>
        </group_list>
        <measure>
          <title>Time Weighted Sum of Change From Baseline in the Back Stiffness Score Over 8 Hours</title>
          <description>Time weighted sum of change calculated as sum of change from baseline in back stiffness scores from 0 through 8 hours, weighted by time duration between current timepoint and previous timepoint. Based on hourly (from baseline) back stiffness assessment rating from 0 (no muscle stiffness) to 100 (most possible muscle stiffness). Sum of change derived by subtracting score at post-dosing time point from baseline score. Total possible score -800 to 800; higher positive value was indicative of greater improvement.</description>
          <population>ITT population.</population>
          <units>scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="5"/>
                <count group_id="O3" value="5"/>
                <count group_id="O4" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="167.0" spread="83.7"/>
                    <measurement group_id="O2" value="140.6" spread="71.3"/>
                    <measurement group_id="O3" value="105.0" spread="143.2"/>
                    <measurement group_id="O4" value="74.5" spread="111.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.002</p_value>
            <p_value_desc>Statistically significant treatment difference was declared if the probability of random occurrence between the treatment groups p-value was ≤0.05.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>P-value calculated using ANOVA model with treatment term only in the model.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to Treatment Failure</title>
        <description>Time to treatment failure defined as time from dosing to the time of rescue medication within the scheduled duration of the study (8 hours); or for participants who withdrew from the study due to lack of efficacy without taking rescue medication, the time of the last assessment was considered the time to treatment failure; or if participant did not take rescue medication, or did not discontinue due to lack of efficacy, the time to treatment failure was considered censored at 8 hours (the scheduled duration of the study).</description>
        <time_frame>Baseline (time of wrap application or oral treatment administration) up to 8 hours</time_frame>
        <population>ITT population. Time to treatment failure not calculable as there were no treatment failures in this study. No participants required use of rescue medication or discontinued study prior to 8 hour evaluation.</population>
        <group_list>
          <group group_id="O1">
            <title>ThermaCare®</title>
            <description>Active treatment low back/hip heatwrap administered one time (could be applied for up to 8 hours); applied within 5 minutes of unsealing the foil wrapper.</description>
          </group>
          <group group_id="O2">
            <title>Sham Wrap (Inactive)</title>
            <description>Inactive heatwrap administered one time as a non-heating wrap; applied within 5 minutes of unsealing the foil wrapper.</description>
          </group>
          <group group_id="O3">
            <title>Oral Ibuprofen (IBU)</title>
            <description>IBU (commercially available Advil®) administered as two 200 milligram (mg) tablets by mouth (PO) as a one time dose.</description>
          </group>
          <group group_id="O4">
            <title>Oral Placebo</title>
            <description>Oral Placebo matching Oral IBU.</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Treatment Failure</title>
          <description>Time to treatment failure defined as time from dosing to the time of rescue medication within the scheduled duration of the study (8 hours); or for participants who withdrew from the study due to lack of efficacy without taking rescue medication, the time of the last assessment was considered the time to treatment failure; or if participant did not take rescue medication, or did not discontinue due to lack of efficacy, the time to treatment failure was considered censored at 8 hours (the scheduled duration of the study).</description>
          <population>ITT population. Time to treatment failure not calculable as there were no treatment failures in this study. No participants required use of rescue medication or discontinued study prior to 8 hour evaluation.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Individual Time-Point Pain Relief Scores</title>
        <description>Pain relief rated hourly (from baseline) by the participant on a 6-point scale: 0=no relief, 1=a little relief, 2=less than half relief, 3=more than half relief, 4=a lot of relief, 5=complete relief.</description>
        <time_frame>At 60, 120, 180, 240, 300, 360, 420, and 480 minutes</time_frame>
        <population>ITT population.</population>
        <group_list>
          <group group_id="O1">
            <title>ThermaCare®</title>
            <description>Active treatment low back/hip heatwrap administered one time (could be applied for up to 8 hours); applied within 5 minutes of unsealing the foil wrapper.</description>
          </group>
          <group group_id="O2">
            <title>Sham Wrap (Inactive)</title>
            <description>Inactive heatwrap administered one time as a non-heating wrap; applied within 5 minutes of unsealing the foil wrapper.</description>
          </group>
          <group group_id="O3">
            <title>Oral Ibuprofen (IBU)</title>
            <description>IBU (commercially available Advil®) administered as two 200 milligram (mg) tablets by mouth (PO) as a one time dose.</description>
          </group>
          <group group_id="O4">
            <title>Oral Placebo</title>
            <description>Oral Placebo matching Oral IBU.</description>
          </group>
        </group_list>
        <measure>
          <title>Individual Time-Point Pain Relief Scores</title>
          <description>Pain relief rated hourly (from baseline) by the participant on a 6-point scale: 0=no relief, 1=a little relief, 2=less than half relief, 3=more than half relief, 4=a lot of relief, 5=complete relief.</description>
          <population>ITT population.</population>
          <units>scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="5"/>
                <count group_id="O3" value="5"/>
                <count group_id="O4" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>60 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.4" spread="1.1"/>
                    <measurement group_id="O2" value="1.0" spread="0.7"/>
                    <measurement group_id="O3" value="1.0" spread="1.4"/>
                    <measurement group_id="O4" value="0.6" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>120 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.1" spread="1.1"/>
                    <measurement group_id="O2" value="1.6" spread="1.3"/>
                    <measurement group_id="O3" value="1.6" spread="1.5"/>
                    <measurement group_id="O4" value="1.2" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>180 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.9" spread="1.2"/>
                    <measurement group_id="O2" value="2.2" spread="1.9"/>
                    <measurement group_id="O3" value="2.4" spread="1.5"/>
                    <measurement group_id="O4" value="1.4" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>240 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.0" spread="1.2"/>
                    <measurement group_id="O2" value="2.2" spread="1.9"/>
                    <measurement group_id="O3" value="2.4" spread="1.8"/>
                    <measurement group_id="O4" value="1.7" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>300 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.1" spread="1.2"/>
                    <measurement group_id="O2" value="2.0" spread="2.0"/>
                    <measurement group_id="O3" value="2.2" spread="1.8"/>
                    <measurement group_id="O4" value="1.5" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>360 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.2" spread="1.2"/>
                    <measurement group_id="O2" value="2.4" spread="1.8"/>
                    <measurement group_id="O3" value="2.4" spread="2.3"/>
                    <measurement group_id="O4" value="1.7" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>420 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.1" spread="1.4"/>
                    <measurement group_id="O2" value="2.0" spread="2.1"/>
                    <measurement group_id="O3" value="2.6" spread="2.4"/>
                    <measurement group_id="O4" value="1.7" spread="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>480 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.2" spread="1.4"/>
                    <measurement group_id="O2" value="2.2" spread="1.9"/>
                    <measurement group_id="O3" value="2.4" spread="2.2"/>
                    <measurement group_id="O4" value="1.7" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>60 minutes timepoint</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.012</p_value>
            <p_value_desc>Statistically significant treatment difference was declared if the probability of random occurrence between the treatment groups p-value was ≤0.05.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>P-value from ANOVA model with treatment term only in the model.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>120 minutes timepoint</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.016</p_value>
            <p_value_desc>Statistically significant treatment difference was declared if the probability of random occurrence between the treatment groups p-value was ≤0.05.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>P-value from ANOVA model with treatment term only in the model.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>180 minutes timepoint</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Statistically significant treatment difference was declared if the probability of random occurrence between the treatment groups p-value was ≤0.05.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>P-value from ANOVA model with treatment term only in the model.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>240 minutes timepoint</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.002</p_value>
            <p_value_desc>Statistically significant treatment difference was declared if the probability of random occurrence between the treatment groups p-value was ≤0.05.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>P-value from ANOVA model with treatment term only in the model.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>300 minutes timepoint</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Statistically significant treatment difference was declared if the probability of random occurrence between the treatment groups p-value was ≤0.05.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>P-value from ANOVA model with treatment term only in the model.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>360 minutes timepoint</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Statistically significant treatment difference was declared if the probability of random occurrence between the treatment groups p-value was ≤0.05.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>P-value from ANOVA model with treatment term only in the model.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>420 minutes timepoint</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.003</p_value>
            <p_value_desc>Statistically significant treatment difference was declared if the probability of random occurrence between the treatment groups p-value was ≤0.05.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>P-value from ANOVA model with treatment term only in the model.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>480 minutes timepoint</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.001</p_value>
            <p_value_desc>Statistically significant treatment difference was declared if the probability of random occurrence between the treatment groups p-value was ≤0.05.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>P-value from ANOVA model with treatment term only in the model.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in Individual Time-point Back Stiffness Scores</title>
        <description>Low back muscle stiffness rated hourly (from baseline) by the participant by placing a line on a visual analog scale (VAS) from 0 millimeters (mm) to 100 mm in length with 0=no muscle stiffness up to 100 (most possible stiffness).</description>
        <time_frame>At 60, 120, 180, 240, 300, 360, 420, and 480 minutes</time_frame>
        <population>ITT population.</population>
        <group_list>
          <group group_id="O1">
            <title>ThermaCare®</title>
            <description>Active treatment low back/hip heatwrap administered one time (could be applied for up to 8 hours); applied within 5 minutes of unsealing the foil wrapper.</description>
          </group>
          <group group_id="O2">
            <title>Sham Wrap (Inactive)</title>
            <description>Inactive heatwrap administered one time as a non-heating wrap; applied within 5 minutes of unsealing the foil wrapper.</description>
          </group>
          <group group_id="O3">
            <title>Oral Ibuprofen (IBU)</title>
            <description>IBU (commercially available Advil®) administered as two 200 milligram (mg) tablets by mouth (PO) as a one time dose.</description>
          </group>
          <group group_id="O4">
            <title>Oral Placebo</title>
            <description>Oral Placebo matching Oral IBU.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Individual Time-point Back Stiffness Scores</title>
          <description>Low back muscle stiffness rated hourly (from baseline) by the participant by placing a line on a visual analog scale (VAS) from 0 millimeters (mm) to 100 mm in length with 0=no muscle stiffness up to 100 (most possible stiffness).</description>
          <population>ITT population.</population>
          <units>scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="5"/>
                <count group_id="O3" value="5"/>
                <count group_id="O4" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>60 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.4" spread="10.8"/>
                    <measurement group_id="O2" value="8.4" spread="10.5"/>
                    <measurement group_id="O3" value="-3.0" spread="8.4"/>
                    <measurement group_id="O4" value="1.3" spread="11.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>120 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.7" spread="10.4"/>
                    <measurement group_id="O2" value="17.6" spread="10.3"/>
                    <measurement group_id="O3" value="8.0" spread="12.5"/>
                    <measurement group_id="O4" value="4.7" spread="11.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>180 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.3" spread="11.8"/>
                    <measurement group_id="O2" value="18.6" spread="12.8"/>
                    <measurement group_id="O3" value="14.0" spread="18.5"/>
                    <measurement group_id="O4" value="8.9" spread="24.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>240 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.7" spread="12.2"/>
                    <measurement group_id="O2" value="17.6" spread="12.1"/>
                    <measurement group_id="O3" value="18.0" spread="20.2"/>
                    <measurement group_id="O4" value="14.0" spread="23.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>300 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.5" spread="11.8"/>
                    <measurement group_id="O2" value="19.2" spread="11.0"/>
                    <measurement group_id="O3" value="18.0" spread="20.2"/>
                    <measurement group_id="O4" value="9.6" spread="17.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>360 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24.5" spread="13.1"/>
                    <measurement group_id="O2" value="20.8" spread="10.6"/>
                    <measurement group_id="O3" value="18.0" spread="22.0"/>
                    <measurement group_id="O4" value="11.5" spread="17.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>420 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.8" spread="15.7"/>
                    <measurement group_id="O2" value="18.0" spread="10.4"/>
                    <measurement group_id="O3" value="18.0" spread="28.0"/>
                    <measurement group_id="O4" value="12.5" spread="17.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>480 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.3" spread="15.8"/>
                    <measurement group_id="O2" value="20.4" spread="10.6"/>
                    <measurement group_id="O3" value="14.0" spread="26.1"/>
                    <measurement group_id="O4" value="12.0" spread="17.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>60 minutes timepoint</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.012</p_value>
            <p_value_desc>Statistically significant treatment difference was declared if the probability of random occurrence between the treatment groups p-value was ≤0.05.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>P-value from ANOVA model with treatment term only in the model.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>120 minutes timepoint</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.002</p_value>
            <p_value_desc>Statistically significant treatment difference was declared if the probability of random occurrence between the treatment groups p-value was ≤0.05.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>P-value from ANOVA model with treatment term only in the model.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>180 minutes timepoint</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.033</p_value>
            <p_value_desc>Statistically significant treatment difference was declared if the probability of random occurrence between the treatment groups p-value was ≤0.05.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>P-value from ANOVA model with treatment term only in the model.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>240 minutes timepoint</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.096</p_value>
            <p_value_desc>Statistically significant treatment difference was declared if the probability of random occurrence between the treatment groups p-value was ≤0.05.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>P-value from ANOVA model with treatment term only in the model.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>300 minutes timepoint</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.002</p_value>
            <p_value_desc>Statistically significant treatment difference was declared if the probability of random occurrence between the treatment groups p-value was ≤0.05.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>P-value from ANOVA model with treatment term only in the model.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>360 minutes timepoint</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.005</p_value>
            <p_value_desc>Statistically significant treatment difference was declared if the probability of random occurrence between the treatment groups p-value was ≤0.05.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>P-value from ANOVA model with treatment term only in the model.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>420 minutes timepoint</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.008</p_value>
            <p_value_desc>Statistically significant treatment difference was declared if the probability of random occurrence between the treatment groups p-value was ≤0.05.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>P-value from ANOVA model with treatment term only in the model.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>480 minutes timepoint</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.004</p_value>
            <p_value_desc>Statistically significant treatment difference was declared if the probability of random occurrence between the treatment groups p-value was ≤0.05.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>P-value from ANOVA model with treatment term only in the model.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline (Bsl) in Combined Flexibility Score: Extension</title>
        <description>Flexibility assessed using Paris Plinth table with maximum extension (as if performing a sit-up) of 20 degrees movement. Angle at Bsl and at 4 hours standardized to 100 for assessment of maximum angle (x degrees), x degrees minus 5, and x degrees plus 5. Flexibility score derived using standardized value and VAS score (participant rating of pain by marking level of pain on 100 mm line 0=no pain up to 100=worst pain). Final derived data for extension flexibility were average of the extension flexibility data on the combined score (range -66 to 552); higher value indicated greater improvement.</description>
        <time_frame>Baseline (time of wrap application or oral treatment administration) and 4 hours</time_frame>
        <population>ITT population.</population>
        <group_list>
          <group group_id="O1">
            <title>ThermaCare®</title>
            <description>Active treatment low back/hip heatwrap administered one time (could be applied for up to 8 hours); applied within 5 minutes of unsealing the foil wrapper.</description>
          </group>
          <group group_id="O2">
            <title>Sham Wrap (Inactive)</title>
            <description>Inactive heatwrap administered one time as a non-heating wrap; applied within 5 minutes of unsealing the foil wrapper.</description>
          </group>
          <group group_id="O3">
            <title>Oral Ibuprofen (IBU)</title>
            <description>IBU (commercially available Advil®) administered as two 200 milligram (mg) tablets by mouth (PO) as a one time dose.</description>
          </group>
          <group group_id="O4">
            <title>Oral Placebo</title>
            <description>Oral Placebo matching Oral IBU.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline (Bsl) in Combined Flexibility Score: Extension</title>
          <description>Flexibility assessed using Paris Plinth table with maximum extension (as if performing a sit-up) of 20 degrees movement. Angle at Bsl and at 4 hours standardized to 100 for assessment of maximum angle (x degrees), x degrees minus 5, and x degrees plus 5. Flexibility score derived using standardized value and VAS score (participant rating of pain by marking level of pain on 100 mm line 0=no pain up to 100=worst pain). Final derived data for extension flexibility were average of the extension flexibility data on the combined score (range -66 to 552); higher value indicated greater improvement.</description>
          <population>ITT population.</population>
          <units>scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="5"/>
                <count group_id="O3" value="5"/>
                <count group_id="O4" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>At Maximum degrees</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.7" spread="34.8"/>
                    <measurement group_id="O2" value="-4.1" spread="35.6"/>
                    <measurement group_id="O3" value="12.7" spread="23.1"/>
                    <measurement group_id="O4" value="4.3" spread="23.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>At Minus 5 degrees</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.7" spread="39.1"/>
                    <measurement group_id="O2" value="8.4" spread="43.2"/>
                    <measurement group_id="O3" value="8.0" spread="39.7"/>
                    <measurement group_id="O4" value="39.0" spread="133.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>At Plus 5 degrees (beyond maximum)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.8" spread="36.4"/>
                    <measurement group_id="O2" value="-5.8" spread="31.6"/>
                    <measurement group_id="O3" value="9.3" spread="30.9"/>
                    <measurement group_id="O4" value="1.5" spread="17.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>At Maximum degrees</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.268</p_value>
            <p_value_desc>Statistically significant treatment difference was declared if the probability of random occurrence between the treatment groups p-value was ≤0.05.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>P-value from ANOVA model with treatment term only in the model.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>At Minus 5 degrees</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.419</p_value>
            <p_value_desc>Statistically significant treatment difference was declared if the probability of random occurrence between the treatment groups p-value was ≤0.05.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>P-value from ANOVA model with treatment term only in the model.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>At Plus 5 degrees (beyond maximum)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.086</p_value>
            <p_value_desc>Statistically significant treatment difference was declared if the probability of random occurrence between the treatment groups p-value was ≤0.05.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>P-value from ANOVA model with treatment term only in the model.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline (Bsl) in Overall Combined Flexibility Score: Side-to-Side</title>
        <description>Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus (+/-) 10 degrees for left, and right (L, R), movement. Angle at Bsl and 4 hours standardized to 100 for assessment of maximum angle (x degrees), x degrees - 5, and x degrees + 5. Flexibility score derived using standardized value and VAS score (participant rating of level of pain on 100 mm line 0=no pain to 100=worst pain). Final derived data for overall flexibility was the average of side-to-side (L, R) flexibility data on the combined score (range -81 to 264); higher value=greater improvement.</description>
        <time_frame>Baseline (time of wrap application or oral treatment administration) and 4 hours</time_frame>
        <population>ITT population.</population>
        <group_list>
          <group group_id="O1">
            <title>ThermaCare®</title>
            <description>Active treatment low back/hip heatwrap administered one time (could be applied for up to 8 hours); applied within 5 minutes of unsealing the foil wrapper.</description>
          </group>
          <group group_id="O2">
            <title>Sham Wrap (Inactive)</title>
            <description>Inactive heatwrap administered one time as a non-heating wrap; applied within 5 minutes of unsealing the foil wrapper.</description>
          </group>
          <group group_id="O3">
            <title>Oral Ibuprofen (IBU)</title>
            <description>IBU (commercially available Advil®) administered as two 200 milligram (mg) tablets by mouth (PO) as a one time dose.</description>
          </group>
          <group group_id="O4">
            <title>Oral Placebo</title>
            <description>Oral Placebo matching Oral IBU.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline (Bsl) in Overall Combined Flexibility Score: Side-to-Side</title>
          <description>Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus (+/-) 10 degrees for left, and right (L, R), movement. Angle at Bsl and 4 hours standardized to 100 for assessment of maximum angle (x degrees), x degrees - 5, and x degrees + 5. Flexibility score derived using standardized value and VAS score (participant rating of level of pain on 100 mm line 0=no pain to 100=worst pain). Final derived data for overall flexibility was the average of side-to-side (L, R) flexibility data on the combined score (range -81 to 264); higher value=greater improvement.</description>
          <population>ITT population.</population>
          <units>scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="5"/>
                <count group_id="O3" value="5"/>
                <count group_id="O4" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>At Maximum degrees</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.9" spread="28.7"/>
                    <measurement group_id="O2" value="14.0" spread="27.2"/>
                    <measurement group_id="O3" value="3.8" spread="21.6"/>
                    <measurement group_id="O4" value="0.7" spread="21.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>At Minus 5 degrees</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.5" spread="37.3"/>
                    <measurement group_id="O2" value="2.3" spread="2.8"/>
                    <measurement group_id="O3" value="-18.0" spread="38.0"/>
                    <measurement group_id="O4" value="14.2" spread="65.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>At Plus 5 degrees (beyond maximum)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.0" spread="32.5"/>
                    <measurement group_id="O2" value="14.8" spread="31.3"/>
                    <measurement group_id="O3" value="10.9" spread="25.1"/>
                    <measurement group_id="O4" value="2.0" spread="14.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>At Maximum degrees</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.067</p_value>
            <p_value_desc>Statistically significant treatment difference was declared if the probability of random occurrence between the treatment groups p-value was ≤0.05.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>P-value from ANOVA model with treatment term only in the model.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>At Minus 5 degrees</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.757</p_value>
            <p_value_desc>Statistically significant treatment difference was declared if the probability of random occurrence between the treatment groups p-value was ≤0.05.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>P-value from ANOVA model with treatment term only in the model.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>At Plus 5 degrees (beyond maximum)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.219</p_value>
            <p_value_desc>Statistically significant treatment difference was declared if the probability of random occurrence between the treatment groups p-value was ≤0.05.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>P-value from ANOVA model with treatment term only in the model.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline (Bsl) in Overall Combined Flexibility Score: Rotation</title>
        <description>Flexibility assessed using Paris Plinth table with maximum rotation at waist of plus or minus (+/-) 30 degrees for left, and right (L, R), movement. Angle at Bsl and at 4 hours standardized to 100 for assessment of maximum angle (x degrees), x degrees - 5, and x degrees + 5. Flexibility score derived using standardized value and VAS score (participant rating of level of pain on 100 mm line 0=no pain up to 100=worst pain). Final derived data for overall flexibility were the average of rotation (L, R) flexibility data on combined score (range -80 to 155); higher value=greater improvement.</description>
        <time_frame>Baseline (time of wrap application or oral treatment administration) and 4 hours</time_frame>
        <population>ITT population.</population>
        <group_list>
          <group group_id="O1">
            <title>ThermaCare®</title>
            <description>Active treatment low back/hip heatwrap administered one time (could be applied for up to 8 hours); applied within 5 minutes of unsealing the foil wrapper.</description>
          </group>
          <group group_id="O2">
            <title>Sham Wrap (Inactive)</title>
            <description>Inactive heatwrap administered one time as a non-heating wrap; applied within 5 minutes of unsealing the foil wrapper.</description>
          </group>
          <group group_id="O3">
            <title>Oral Ibuprofen (IBU)</title>
            <description>IBU (commercially available Advil®) administered as two 200 milligram (mg) tablets by mouth (PO) as a one time dose.</description>
          </group>
          <group group_id="O4">
            <title>Oral Placebo</title>
            <description>Oral Placebo matching Oral IBU.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline (Bsl) in Overall Combined Flexibility Score: Rotation</title>
          <description>Flexibility assessed using Paris Plinth table with maximum rotation at waist of plus or minus (+/-) 30 degrees for left, and right (L, R), movement. Angle at Bsl and at 4 hours standardized to 100 for assessment of maximum angle (x degrees), x degrees - 5, and x degrees + 5. Flexibility score derived using standardized value and VAS score (participant rating of level of pain on 100 mm line 0=no pain up to 100=worst pain). Final derived data for overall flexibility were the average of rotation (L, R) flexibility data on combined score (range -80 to 155); higher value=greater improvement.</description>
          <population>ITT population.</population>
          <units>scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="5"/>
                <count group_id="O3" value="5"/>
                <count group_id="O4" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>At Maximum degrees</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.9" spread="19.0"/>
                    <measurement group_id="O2" value="24.1" spread="12.5"/>
                    <measurement group_id="O3" value="12.1" spread="18.5"/>
                    <measurement group_id="O4" value="-0.2" spread="16.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>At Minus 5 degrees</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.0" spread="33.3"/>
                    <measurement group_id="O2" value="35.9" spread="22.0"/>
                    <measurement group_id="O3" value="6.8" spread="21.5"/>
                    <measurement group_id="O4" value="4.1" spread="42.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>At Plus 5 degrees (beyond maximum)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.0" spread="22.2"/>
                    <measurement group_id="O2" value="33.4" spread="27.2"/>
                    <measurement group_id="O3" value="14.5" spread="19.8"/>
                    <measurement group_id="O4" value="-1.4" spread="13.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>At Maximum degrees</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.043</p_value>
            <p_value_desc>Statistically significant treatment difference was declared if the probability of random occurrence between the treatment groups p-value was ≤0.05.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>P-value from ANOVA model with treatment term only in the model.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>At Minus 5 degrees</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.388</p_value>
            <p_value_desc>Statistically significant treatment difference was declared if the probability of random occurrence between the treatment groups p-value was ≤0.05.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>P-value from ANOVA model with treatment term only in the model.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>At Plus 5 degrees (beyond maximum)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.039</p_value>
            <p_value_desc>Statistically significant treatment difference was declared if the probability of random occurrence between the treatment groups p-value was ≤0.05.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>P-value from ANOVA model with treatment term only in the model.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in the Angle Measurement at Maximum Flexion for Flexibility Measures: Extension</title>
        <description>Participant placed in a prone position on Paris Plinth table which is moved at 1 degree per second to maximum movement of 20 degrees for extension (as if performing a sit-up) to the degree of movement at which participant perceives discomfort or pain. Higher score indicated greater improvement.</description>
        <time_frame>Baseline (time of wrap application or oral treatment administration) and 4 hours</time_frame>
        <population>ITT population.</population>
        <group_list>
          <group group_id="O1">
            <title>ThermaCare®</title>
            <description>Active treatment low back/hip heatwrap administered one time (could be applied for up to 8 hours); applied within 5 minutes of unsealing the foil wrapper.</description>
          </group>
          <group group_id="O2">
            <title>Sham Wrap (Inactive)</title>
            <description>Inactive heatwrap administered one time as a non-heating wrap; applied within 5 minutes of unsealing the foil wrapper.</description>
          </group>
          <group group_id="O3">
            <title>Oral Ibuprofen (IBU)</title>
            <description>IBU (commercially available Advil®) administered as two 200 milligram (mg) tablets by mouth (PO) as a one time dose.</description>
          </group>
          <group group_id="O4">
            <title>Oral Placebo</title>
            <description>Oral Placebo matching Oral IBU.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in the Angle Measurement at Maximum Flexion for Flexibility Measures: Extension</title>
          <description>Participant placed in a prone position on Paris Plinth table which is moved at 1 degree per second to maximum movement of 20 degrees for extension (as if performing a sit-up) to the degree of movement at which participant perceives discomfort or pain. Higher score indicated greater improvement.</description>
          <population>ITT population.</population>
          <units>degrees</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="5"/>
                <count group_id="O3" value="5"/>
                <count group_id="O4" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.4" spread="3.0"/>
                    <measurement group_id="O2" value="-1.1" spread="3.1"/>
                    <measurement group_id="O3" value="0.5" spread="2.9"/>
                    <measurement group_id="O4" value="1.2" spread="4.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.797</p_value>
            <p_value_desc>Statistically significant treatment difference was declared if the probability of random occurrence between the treatment groups p-value was ≤0.05.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>P-value from ANOVA model with treatment term only in the model.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in the Angle Measurement at Maximum Flexion for Flexibility Measures: Side-to-Side</title>
        <description>Participant placed in a prone position on Paris Plinth table which is moved at 1 degree per second to maximum movement +/- 10 degrees for left, and right, side-to-side movement to the degree of movement at which participant perceives discomfort or pain. Maximum flexion based on the average of the left and right side-to-side scores. Higher score indicated greater improvement.</description>
        <time_frame>Baseline (time of wrap application or oral treatment administration) and 4 hours</time_frame>
        <population>ITT population.</population>
        <group_list>
          <group group_id="O1">
            <title>ThermaCare®</title>
            <description>Active treatment low back/hip heatwrap administered one time (could be applied for up to 8 hours); applied within 5 minutes of unsealing the foil wrapper.</description>
          </group>
          <group group_id="O2">
            <title>Sham Wrap (Inactive)</title>
            <description>Inactive heatwrap administered one time as a non-heating wrap; applied within 5 minutes of unsealing the foil wrapper.</description>
          </group>
          <group group_id="O3">
            <title>Oral Ibuprofen (IBU)</title>
            <description>IBU (commercially available Advil®) administered as two 200 milligram (mg) tablets by mouth (PO) as a one time dose.</description>
          </group>
          <group group_id="O4">
            <title>Oral Placebo</title>
            <description>Oral Placebo matching Oral IBU.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in the Angle Measurement at Maximum Flexion for Flexibility Measures: Side-to-Side</title>
          <description>Participant placed in a prone position on Paris Plinth table which is moved at 1 degree per second to maximum movement +/- 10 degrees for left, and right, side-to-side movement to the degree of movement at which participant perceives discomfort or pain. Maximum flexion based on the average of the left and right side-to-side scores. Higher score indicated greater improvement.</description>
          <population>ITT population.</population>
          <units>degrees</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="5"/>
                <count group_id="O3" value="5"/>
                <count group_id="O4" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1" spread="1.2"/>
                    <measurement group_id="O2" value="0.4" spread="1.0"/>
                    <measurement group_id="O3" value="-0.3" spread="0.4"/>
                    <measurement group_id="O4" value="-0.2" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.371</p_value>
            <p_value_desc>Statistically significant treatment difference was declared if the probability of random occurrence between the treatment groups p-value was ≤0.05.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>P-value from ANOVA model with treatment term only in the model.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in the Angle Measurement at Maximum Flexion for Flexibility Measures: Rotation</title>
        <description>Participant placed in a prone position on Paris Plinth table which is moved at 1 degree per second to maximum rotation at waist of +/- 30 degrees for left, and right, movement to the degree of movement at which participant perceives discomfort or pain. Maximum flexion based on the average of the left and right rotation scores. Higher score indicated greater improvement.</description>
        <time_frame>Baseline (time of wrap application or oral treatment administration) and 4 hours</time_frame>
        <population>ITT population.</population>
        <group_list>
          <group group_id="O1">
            <title>ThermaCare®</title>
            <description>Active treatment low back/hip heatwrap administered one time (could be applied for up to 8 hours); applied within 5 minutes of unsealing the foil wrapper.</description>
          </group>
          <group group_id="O2">
            <title>Sham Wrap (Inactive)</title>
            <description>Inactive heatwrap administered one time as a non-heating wrap; applied within 5 minutes of unsealing the foil wrapper.</description>
          </group>
          <group group_id="O3">
            <title>Oral Ibuprofen (IBU)</title>
            <description>IBU (commercially available Advil®) administered as two 200 milligram (mg) tablets by mouth (PO) as a one time dose.</description>
          </group>
          <group group_id="O4">
            <title>Oral Placebo</title>
            <description>Oral Placebo matching Oral IBU.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in the Angle Measurement at Maximum Flexion for Flexibility Measures: Rotation</title>
          <description>Participant placed in a prone position on Paris Plinth table which is moved at 1 degree per second to maximum rotation at waist of +/- 30 degrees for left, and right, movement to the degree of movement at which participant perceives discomfort or pain. Maximum flexion based on the average of the left and right rotation scores. Higher score indicated greater improvement.</description>
          <population>ITT population.</population>
          <units>degrees</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="5"/>
                <count group_id="O3" value="5"/>
                <count group_id="O4" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.6" spread="2.5"/>
                    <measurement group_id="O2" value="1.3" spread="1.4"/>
                    <measurement group_id="O3" value="-0.6" spread="0.6"/>
                    <measurement group_id="O4" value="-0.6" spread="3.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.122</p_value>
            <p_value_desc>Statistically significant treatment difference was declared if the probability of random occurrence between the treatment groups p-value was ≤0.05.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>P-value from ANOVA model with treatment term only in the model.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline (Bsl) in Pain Measurement for Flexibility Measure: Extension</title>
        <description>Flexibility assessed using Paris Plinth table with maximum extension of 20 degrees movement (as if performing a sit-up). When participant feels discomfort or pain, participant places a mark to rate discomfort/pain (maximum) on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees (minus) and discomfort rated on VAS. Movement increased 5 degrees (plus) beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher score indicated greater discomfort/pain.</description>
        <time_frame>Baseline (time of wrap application or oral treatment administration) and 4 hours</time_frame>
        <population>ITT population.</population>
        <group_list>
          <group group_id="O1">
            <title>ThermaCare®</title>
            <description>Active treatment low back/hip heatwrap administered one time (could be applied for up to 8 hours); applied within 5 minutes of unsealing the foil wrapper.</description>
          </group>
          <group group_id="O2">
            <title>Sham Wrap (Inactive)</title>
            <description>Inactive heatwrap administered one time as a non-heating wrap; applied within 5 minutes of unsealing the foil wrapper.</description>
          </group>
          <group group_id="O3">
            <title>Oral Ibuprofen (IBU)</title>
            <description>IBU (commercially available Advil®) administered as two 200 milligram (mg) tablets by mouth (PO) as a one time dose.</description>
          </group>
          <group group_id="O4">
            <title>Oral Placebo</title>
            <description>Oral Placebo matching Oral IBU.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline (Bsl) in Pain Measurement for Flexibility Measure: Extension</title>
          <description>Flexibility assessed using Paris Plinth table with maximum extension of 20 degrees movement (as if performing a sit-up). When participant feels discomfort or pain, participant places a mark to rate discomfort/pain (maximum) on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees (minus) and discomfort rated on VAS. Movement increased 5 degrees (plus) beyond first point when pain was reported and discomfort/pain again rated on the VAS. Higher score indicated greater discomfort/pain.</description>
          <population>ITT population.</population>
          <units>scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="5"/>
                <count group_id="O3" value="5"/>
                <count group_id="O4" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>At Maximum degrees</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.7" spread="25.0"/>
                    <measurement group_id="O2" value="-0.8" spread="32.9"/>
                    <measurement group_id="O3" value="10.4" spread="15.4"/>
                    <measurement group_id="O4" value="-0.6" spread="11.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>At Minus 5 degrees</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.7" spread="15.1"/>
                    <measurement group_id="O2" value="7.4" spread="24.7"/>
                    <measurement group_id="O3" value="7.2" spread="23.3"/>
                    <measurement group_id="O4" value="-1.8" spread="17.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>At Plus 5 degrees (beyond maximum)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.5" spread="24.7"/>
                    <measurement group_id="O2" value="-5.6" spread="32.1"/>
                    <measurement group_id="O3" value="12.6" spread="30.7"/>
                    <measurement group_id="O4" value="2.0" spread="11.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>At Maximum degrees</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.355</p_value>
            <p_value_desc>Statistically significant treatment difference was declared if the probability of random occurrence between the treatment groups p-value was ≤0.05.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>P-value from ANOVA model with treatment term only in the model.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>At Minus 5 degrees</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.371</p_value>
            <p_value_desc>Statistically significant treatment difference was declared if the probability of random occurrence between the treatment groups p-value was ≤0.05.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>P-value from ANOVA model with treatment term only in the model.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>At Plus 5 degrees (beyond maximum)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.216</p_value>
            <p_value_desc>Statistically significant treatment difference was declared if the probability of random occurrence between the treatment groups p-value was ≤0.05.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>P-values from ANOVA model with treatment treatment term only in the model.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in Pain Measurement for Flexibility Measure: Side-to-Side</title>
        <description>Flexibility assessed using Paris Plinth table with maximum side-to-side movement of +/- 10 degrees for L, R movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain (maximum) on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees (minus) and discomfort rated on VAS. Movement increased 5 degrees (plus) beyond first point when pain was reported and discomfort/pain again rated on the VAS. Analyses based on the average of L, R scores. Higher score indicated greater discomfort/pain.</description>
        <time_frame>Baseline (time of wrap application or oral treatment administration) and 4 hours</time_frame>
        <population>ITT population.</population>
        <group_list>
          <group group_id="O1">
            <title>ThermaCare®</title>
            <description>Active treatment low back/hip heatwrap administered one time (could be applied for up to 8 hours); applied within 5 minutes of unsealing the foil wrapper.</description>
          </group>
          <group group_id="O2">
            <title>Sham Wrap (Inactive)</title>
            <description>Inactive heatwrap administered one time as a non-heating wrap; applied within 5 minutes of unsealing the foil wrapper.</description>
          </group>
          <group group_id="O3">
            <title>Oral Ibuprofen (IBU)</title>
            <description>IBU (commercially available Advil®) administered as two 200 milligram (mg) tablets by mouth (PO) as a one time dose.</description>
          </group>
          <group group_id="O4">
            <title>Oral Placebo</title>
            <description>Oral Placebo matching Oral IBU.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Pain Measurement for Flexibility Measure: Side-to-Side</title>
          <description>Flexibility assessed using Paris Plinth table with maximum side-to-side movement of +/- 10 degrees for L, R movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain (maximum) on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees (minus) and discomfort rated on VAS. Movement increased 5 degrees (plus) beyond first point when pain was reported and discomfort/pain again rated on the VAS. Analyses based on the average of L, R scores. Higher score indicated greater discomfort/pain.</description>
          <population>ITT population.</population>
          <units>scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="5"/>
                <count group_id="O3" value="5"/>
                <count group_id="O4" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>At Maximum degrees</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.9" spread="13.4"/>
                    <measurement group_id="O2" value="5.0" spread="10.9"/>
                    <measurement group_id="O3" value="6.6" spread="21.2"/>
                    <measurement group_id="O4" value="-0.3" spread="15.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>At Minus 5 degrees</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.2" spread="10.7"/>
                    <measurement group_id="O2" value="4.6" spread="5.8"/>
                    <measurement group_id="O3" value="2.2" spread="18.3"/>
                    <measurement group_id="O4" value="2.6" spread="10.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>At Plus 5 degrees (beyond maximum)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.9" spread="18.1"/>
                    <measurement group_id="O2" value="7.3" spread="16.0"/>
                    <measurement group_id="O3" value="11.2" spread="25.4"/>
                    <measurement group_id="O4" value="0.9" spread="12.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>At Maximum degrees</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.054</p_value>
            <p_value_desc>Statistically significant treatment difference was declared if the probability of random occurrence between the treatment groups p-value was ≤0.05.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>P-value from ANOVA model with treatment term only in the model.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>At Minus 5 degrees</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.600</p_value>
            <p_value_desc>Statistically significant treatment difference was declared if the probability of random occurrence between the treatment groups p-value was ≤0.05.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>P-value from ANOVA model with treatment term only in the model.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>At Plus 5 degrees (beyond maximum)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.294</p_value>
            <p_value_desc>Statistically significant treatment difference was declared if the probability of random occurrence between the treatment groups p-value was ≤0.05.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>P-value from ANOVA model with treatment term only in the model.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in Pain Measurement for Flexibility Measure: Rotation</title>
        <description>Flexibility assessed using Paris Plinth table with maximum rotation at waist of +/- 30 degrees for L, R movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain (maximum) on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees (minus) and discomfort rated on VAS. Movement increased 5 degrees (plus) beyond first point when pain was reported and discomfort/pain again rated on the VAS. Analyses based on the average of L, R scores. Higher score indicated greater discomfort/pain.</description>
        <time_frame>Baseline (time of wrap application or oral treatment administration) and 4 hours</time_frame>
        <population>ITT population.</population>
        <group_list>
          <group group_id="O1">
            <title>ThermaCare®</title>
            <description>Active treatment low back/hip heatwrap administered one time (could be applied for up to 8 hours); applied within 5 minutes of unsealing the foil wrapper.</description>
          </group>
          <group group_id="O2">
            <title>Sham Wrap (Inactive)</title>
            <description>Inactive heatwrap administered one time as a non-heating wrap; applied within 5 minutes of unsealing the foil wrapper.</description>
          </group>
          <group group_id="O3">
            <title>Oral Ibuprofen (IBU)</title>
            <description>IBU (commercially available Advil®) administered as two 200 milligram (mg) tablets by mouth (PO) as a one time dose.</description>
          </group>
          <group group_id="O4">
            <title>Oral Placebo</title>
            <description>Oral Placebo matching Oral IBU.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Pain Measurement for Flexibility Measure: Rotation</title>
          <description>Flexibility assessed using Paris Plinth table with maximum rotation at waist of +/- 30 degrees for L, R movement. When participant feels discomfort or pain, participant places a mark to rate discomfort/pain (maximum) on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain. Movement decreased 5 degrees (minus) and discomfort rated on VAS. Movement increased 5 degrees (plus) beyond first point when pain was reported and discomfort/pain again rated on the VAS. Analyses based on the average of L, R scores. Higher score indicated greater discomfort/pain.</description>
          <population>ITT population.</population>
          <units>scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="5"/>
                <count group_id="O3" value="5"/>
                <count group_id="O4" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>At Maximum degrees</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.4" spread="15.9"/>
                    <measurement group_id="O2" value="17.4" spread="9.0"/>
                    <measurement group_id="O3" value="15.7" spread="18.9"/>
                    <measurement group_id="O4" value="0.2" spread="13.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>At Minus 5 degrees</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.4" spread="17.8"/>
                    <measurement group_id="O2" value="19.4" spread="8.4"/>
                    <measurement group_id="O3" value="12.5" spread="15.6"/>
                    <measurement group_id="O4" value="3.2" spread="13.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>At Plus 5 degrees (beyond maximum)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.3" spread="21.5"/>
                    <measurement group_id="O2" value="25.4" spread="14.1"/>
                    <measurement group_id="O3" value="20.9" spread="18.1"/>
                    <measurement group_id="O4" value="-1.2" spread="12.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>At Maximum degrees</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.088</p_value>
            <p_value_desc>Statistically significant treatment difference was declared if the probability of random occurrence between the treatment groups p-value was ≤0.05.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>P-value from ANOVA model with treatment term only in the model.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>At Minus 5 degrees</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.625</p_value>
            <p_value_desc>Statistically significant treatment difference was declared if the probability of random occurrence between the treatment groups p-value was ≤0.05.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>P-value from ANOVA model with treatment term only in the model.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>At Plus 5 degrees (beyond maximum)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.034</p_value>
            <p_value_desc>Statistically significant treatment difference was declared if the probability of random occurrence between the treatment groups p-value was ≤0.05.</p_value_desc>
            <method>ANOVA</method>
            <method_desc>P-value from ANOVA model with treatment term only in the model.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Per Categorical Score for Global Assessment of Study Treatment</title>
        <description>At hour 8, or at the time of rescue, if it occurred, participants performed a global assessment in their diary in response to the question: How would you rate the study treatment as a pain reliever? Very Poor=0, Poor=1, Fair=2, Good=3, Very Good=4, Excellent=5.</description>
        <time_frame>Baseline (time of wrap application or oral treatment administration) up to 8 hours</time_frame>
        <population>ITT population.</population>
        <group_list>
          <group group_id="O1">
            <title>ThermaCare®</title>
            <description>Active treatment low back/hip heatwrap administered one time (could be applied for up to 8 hours); applied within 5 minutes of unsealing the foil wrapper.</description>
          </group>
          <group group_id="O2">
            <title>Sham Wrap (Inactive)</title>
            <description>Inactive heatwrap administered one time as a non-heating wrap; applied within 5 minutes of unsealing the foil wrapper.</description>
          </group>
          <group group_id="O3">
            <title>Oral Ibuprofen (IBU)</title>
            <description>IBU (commercially available Advil®) administered as two 200 milligram (mg) tablets by mouth (PO) as a one time dose.</description>
          </group>
          <group group_id="O4">
            <title>Oral Placebo</title>
            <description>Oral Placebo matching Oral IBU.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Per Categorical Score for Global Assessment of Study Treatment</title>
          <description>At hour 8, or at the time of rescue, if it occurred, participants performed a global assessment in their diary in response to the question: How would you rate the study treatment as a pain reliever? Very Poor=0, Poor=1, Fair=2, Good=3, Very Good=4, Excellent=5.</description>
          <population>ITT population.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="5"/>
                <count group_id="O3" value="5"/>
                <count group_id="O4" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Very poor=0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Poor=1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fair=2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Good=3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Very good=4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Excellent=5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Response missing</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Statistically significant treatment difference was declared if the probability of random occurrence between the treatment groups p-value was ≤0.05.</p_value_desc>
            <method>Cochran-Mantel-Haenszel</method>
            <method_desc>P-value from the Cochran-Mantel-Haenszel test with modified ridit scores.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Baseline up to 5 days after the 8 hour evaluation period.</time_frame>
      <desc>The same event may appear as both an AE and a SAE. However, what is presented are distinct events. An event may be categorized as serious in one subject and as nonserious in another subject, or one subject may have experienced both a serious and nonserious event during the study.</desc>
      <group_list>
        <group group_id="E1">
          <title>ThermaCare®</title>
          <description>Active treatment low back/hip heatwrap administered one time (could be applied for up to 8 hours); applied within 5 minutes of unsealing the foil wrapper.</description>
        </group>
        <group group_id="E2">
          <title>Sham Wrap (Inactive)</title>
          <description>Inactive heatwrap administered one time as a non-heating wrap; applied within 5 minutes of unsealing the foil wrapper.</description>
        </group>
        <group group_id="E3">
          <title>Oral Ibuprofen (IBU)</title>
          <description>IBU (commercially available Advil®) administered as two 200 milligram (mg) tablets by mouth (PO) as a one time dose.</description>
        </group>
        <group group_id="E4">
          <title>Oral Placebo</title>
          <description>Oral Placebo matching Oral IBU.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_vocab>MedDRA (13.0)</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="26"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="26"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after the disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.</restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>No primary endpoint was prespecified in this Pilot study; 1 key efficacy endpoint was selected for reporting purposes only.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Pfizer ClinicalTrials.gov Call Center</name_or_title>
      <organization>Pfizer, Inc.</organization>
      <phone>1-800-718-1021</phone>
      <email>ClinicalTrials.govCallCenter@pfizer.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

